Bismuth Subcitrate/Metronidazole/ Tetracycline -Axcan Pharma: Bismuth Triple Therapy - Axcan Pharma, Helicide

Author：

ISSN： 1174-5886

Source： Drugs in R&D, Vol.3, Iss.6, 2002-01, pp. : 402-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule

By Boer Wink A de

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite

New Ammunition for the Pharma Industry

By Wright Tracey

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 5, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Big Pharma's Recent Challenges

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 1, 2014-04 ,pp. : 28-36

Bentham Science Publishers

Access to resources Recommend Favorite

An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 200-208

Bentham Science Publishers

Access to resources Recommend Favorite

Beclometasone Oral - DOR BioPharma: Beclomethasone Oral - DOR BioPharma

By Adis International Limited

Drugs in R&D, Vol. 9, Iss. 4, 2008-01 ,pp. : 271-276

Adis International

Access to resources Recommend Favorite